| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6242374 | Respiratory Medicine | 2014 | 7 Pages |
Abstract
Plasma adiponectin levels were associated with peripheral airway obstruction and dynamic hyperinflation in patients with COPD. A higher adiponectin level predicted more favourable relief of symptoms and hyperinflation during glucocorticoid treatment. Adiponectin may have a role in the COPD pathogenesis; it may also be a biomarker of disease severity and treatment responses in this disease.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Sirpa Leivo-Korpela, Lauri Lehtimäki, Katriina Vuolteenaho, Riina Nieminen, Lea Kööbi, Ritva Järvenpää, Hannu Kankaanranta, Seppo Saarelainen, Eeva Moilanen,